Titre:
  • Valproate-doxorubicin: promising therapy for progressing mesothelioma. A phase II study.
Auteur:Scherpereel, Arnaud; Berghmans, Thierry; Lafitte, Jean-Jacques; Colinet, Benoît; Richez, Michel; Bonduelle, Yves; Meert, Anne-Pascale; Dhalluin, X; Leclercq, Nathalie; Paesmans, Marianne; Willems, Lucas; Sculier, Jean-Paul; European Lung Cancer Working Party (ELCWP),
Informations sur la publication:The European respiratory journal, 37, 1, page (129-135)
Statut de publication:Publié, 2011-01
Sujet CREF:Sciences bio-médicales et agricoles
Mots-clés:Chemotherapy
Doxorubicin
Histone deacetylase inhibitors
Mesothelioma
Valproic acid
MeSH keywords:Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use
Disease Progression
Disease-Free Survival
Doxorubicin -- administration & dosage
Female
Histone Deacetylase Inhibitors -- administration & dosage
Humans
Lung Neoplasms -- drug therapy -- mortality
Male
Mesothelioma -- drug therapy
Middle Aged
Protein Isoforms
Valproic Acid -- administration & dosage
Note générale:Clinical Trial, Phase II
Journal Article
Research Support, Non-U.S. Gov't
SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0903-1936
info:doi/10.1183/09031936.00037310
info:pii/09031936.00037310
info:scp/79251559363
info:pmid/20530048